As PROTACs technology has become an emerging strategy for drug development, the toxicological issue is one of the main challenges for PROTACs application in drug delivery at present. Cytotoxicity assay is a common method to study the toxicity of molecules in cellular systems, and Profacgen offers apoptosis assays to help our customers address this issue in vitro. We provide different detection methods for different stages of apoptosis, including but not limited to:

https://www.profacgen.com/apoptosis-assays.htm

Profacgen offers a full range of biopharmaceutical development and bio-manufacturing services that cover strategic consultancy, world-class process development, cGMP manufacturing, and analytical development.